XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (9,810) $ (24,022)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 124 49
Change in fair value of simple agreements for future equity 0 16,793
Accretion of discount on marketable debt securities (312) 0
Stock-based compensation 2,311 667
Deferred income taxes (4,734) 0
Change in operating assets and liabilities, net of effect of acquisition:    
Prepaid and other current assets 336 (291)
Other assets (17) 25
Accounts payable (1,755) (574)
Accrued expenses and other 1,606 73
Operating lease right-of-use assets and liabilities 8 (7)
Net cash used in operating activities (12,243) (7,287)
Cash flows from investing activities:    
Purchases of property and equipment (332) (97)
Purchases of marketable debt securities (29,887) 0
Proceeds from redemptions of marketable debt securities 37,183 0
Payment for acquisition of business, net of cash acquired (900) 0
Net cash provided by (used in) investing activities: 6,064 (97)
Cash flows from financing activities:    
Payment of taxes from common stock withheld (1,595) 0
Proceeds from exercise of stock options 720 440
Proceeds from right of first refusal liability 0 25,000
Proceeds from simple agreements for future equity 0 10,232
Payment of deferred issuance costs 0 (137)
Net cash (used in) provided by financing activities (875) 35,535
Net (decrease) increase in cash and cash equivalents (7,054) 28,151
Cash and cash equivalents - beginning of period 97,132 9,868
Cash and cash equivalents - end of period 90,078 38,019
Supplemental noncash investing and financing activities:    
Issuance of common stock in connection with acquisition of business 27,408 0
Assumed liabilities in connection with acquisition of business 287 0
Deferred issuance costs included in accrued expense and other 0 800
Reclassification of simple agreements for future equity in connection with business combination $ 0 $ 204